Literature DB >> 1393263

Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.

M Schwanstecher1, C Brandt, S Behrends, U Schaupp, U Panten.   

Abstract

1. The effects of blockers and openers of K+ channels on binding of [3H]-glibenclamide to microsomes obtained from a pancreatic beta-cell line (HIT-T15) or rat cerebral cortex were examined. 2. The blockers quinine, chlorpromazine and thiopentone and the openers cromakalim [(+/- ) 6-cyano-3,4-dihydro-2,2-dimethyl-trans-4-(2-oxo-1- pyrrolidyl)-2H-benzo[b]pyran-3-ol] and minoxidil sulphate did not significantly interact with the sulphonylurea receptor of HIT-cells both at phosphorylating (presence of MgATP) and dephosphorylating (absence of MgATP) conditions. 3. In the absence of MgATP, pinacidil (200-500 microM) did not significantly displace [3H]-glibenclamide binding to microsomes from HIT-cells. The displacement of [3H]-glibenclamide binding was strongly enhanced by MgATP and was due to a decrease in the number of high affinity binding sites for glibenclamide. 4. MgATP enhanced pinacidil-induced inhibition of [3H]-glibenclamide binding to microsomes from rat cerebral cortex. 5. The effect of MgATP on pinacidil-induced inhibition of [3H]-glibenclamide binding was maintained after solubilization of the membranes from HIT-cells or rat cerebral cortex. 6. It is concluded that the sulphonylurea receptor is regulated not only by sulphonylureas but also by the K+ channel openers, diazoxide and pinacidil, and by protein phosphorylation. The binding sites for sulphonylureas and these K+ channel openers are not identical, but appear to be located at a single protein or at tightly associated proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393263      PMCID: PMC1907491          DOI: 10.1111/j.1476-5381.1992.tb14331.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  48 in total

1.  The binding site for [3H]glibenclamide in the rat cerebral cortex does not recognize K-channel agonists or antagonists other than sulphonylureas.

Authors:  I Angel; S Bidet
Journal:  Fundam Clin Pharmacol       Date:  1991       Impact factor: 2.748

2.  Chlorpromazine and related phenothiazines inhibit the ATP-sensitive K+ channel.

Authors:  M Müller; J R De Weille; M Lazdunski
Journal:  Eur J Pharmacol       Date:  1991-05-30       Impact factor: 4.432

3.  Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.

Authors:  H J Petersen; C K Nielsen; E Arrigoni-Martelli
Journal:  J Med Chem       Date:  1978-08       Impact factor: 7.446

4.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

5.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

6.  Adenine nucleotide-induced inhibition of binding of sulphonylureas to their receptor in pancreatic islets.

Authors:  M Schwanstecher; S Löser; C Brandt; K Scheffer; F Rosenberger; U Panten
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

7.  The regional distribution of sulphonylurea binding sites in rat brain.

Authors:  J M Treherne; M L Ashford
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

8.  Allosteric coupling between morphine and enkephalin receptors in vitro.

Authors:  R B Rothman; T C Westfall
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

9.  Chiral recognition of pinacidil and its 3-pyridyl isomer by canine cardiac and smooth muscle: antagonism by sulfonylureas.

Authors:  M I Steinberg; S A Wiest; K M Zimmerman; P J Ertel; K G Bemis; D W Robertson
Journal:  J Pharmacol Exp Ther       Date:  1991-01       Impact factor: 4.030

10.  Phosphate and thiophosphate group donating adenine and guanine nucleotides inhibit glibenclamide binding to membranes from pancreatic islets.

Authors:  M Schwanstecher; S Löser; I Rietze; U Panten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

View more
  18 in total

1.  Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure.

Authors:  P W Manley; C Löffler-Walz; U Russ; A Hambrock; T Moenius; U Quast
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels.

Authors:  Christopher J Lynch; Qing Zhou; Show-Ling Shyng; David J Heal; Sharon C Cheetham; Keith Dickinson; Peter Gregory; Michael Firnges; Ulrich Nordheim; Stephanie Goshorn; Dania Reiche; Lechoslaw Turski; Jochen Antel
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-13       Impact factor: 4.310

3.  Binding and effect of K ATP channel openers in the absence of Mg2+.

Authors:  Ulrich Russ; Ulf Lange; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 4.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

5.  The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.

Authors:  Damian Stephan; Eva Stauss; Ulf Lange; Holger Felsch; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Russ; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

6.  Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans.

Authors:  P J Bijlstra; J A Lutterman; F G Russel; T Thien; P Smits
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

7.  Location of the sulphonylurea receptor at the cytoplasmic face of the beta-cell membrane.

Authors:  M Schwanstecher; C Schwanstecher; C Dickel; F Chudziak; A Moshiri; U Panten
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

8.  Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes.

Authors:  M Meyer; F Chudziak; C Schwanstecher; M Schwanstecher; U Panten
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

9.  Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.

Authors:  Annette Hambrock; Cornelia Löffler-Walz; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

10.  Regional and species differences in glyburide-sensitive K+ channels in airway smooth muscles as estimated from actions of KC 128 and levcromakalim.

Authors:  K Kamei; S Yoshida; J Imagawa; H Nabata; H Kuriyama
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.